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Abstract The canonical role of p53 in preserving genome
integrity and limiting carcinogenesis has been well estab-
lished. In the presence of acute DNA-damage, oncogene
deregulation and other forms of cellular stress, p53
orchestrates a myriad of pleiotropic processes to repair
cellular damages and maintain homeostasis. Beside these
well-studied functions of p53, recent studies in Drosophila
have unraveled intriguing roles of Dmp53 in promoting
cell division in apoptosis-induced proliferation, enhancing
fitness and proliferation of the winner cell in cell compe-
tition and coordinating growth at the organ and organismal
level in the presence of stress. In this review, we describe
these new functions of Dmp53 and discuss their relevance
in the context of carcinogenesis.
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Introduction
The p53 protein is the product of the tumor suppressor
gene, TP53. It is a member of the p53 superfamily proteins
that comprise TP53, TP63 and TP73. p53 is mutated or
inactivated in more than half of human cancers. Early
works on p53 have elucidated its canonical function in
response to DNA damage. Specifically, in the presence of
mild stress or damage signal, p53 blocks cell cycle pro-
gression and activates DNA repair machinery to promote
cell survival and maintain genome integrity. However,
when the damage is extensive, p53 drives cellular senes-
cence or irreversible apoptosis to eliminate the potentially
oncogenic cells with genomic instability and therefore
reduces the risk of tumorigenesis [1, 2]. In addition, other
types of cellular stresses such as starvation and metabolic
stress also activate p53 response pathways such as the anti-
oxidant response and autophagy [3–6].
The classic model organism Drosophila is instrumental
to study the pleiotropic functions of p53 in both stress
response and development [7]. In 2000, three research
groups independently cloned Drosophila melanogaster p53
(Dmp53) and found it to be the only member of the p53
family proteins in flies [8–10]. In contrast to all p63-like
proteins, Dmp53 lacks a SAM domain. The absence of the
SAM domain, along with the initial observation that
Dmp53 binds to the reaper (rpr) promoter and activates IR-
induced damage response, led the investigators to propose
that Dmp53 is a p53 homologue [8–10]. Earlier Drosophila
studies showed that after irradiation treatment, Dmp53
mediates apoptosis but not cell cycle arrest [10]. Such
mode of damage response is reminiscent of that mediated
by p63. Therefore, it was proposed that Dmp53 may cap-
ture certain features of p63 but has lost its SAM domain
during evolution (reviewed in [11]). This is supported by
the fact that in some invertebrates such as the C. elegans,
the p53 homologue, cep-1 still harbors a SAM domain.
However, studies from Banerjee and col. have challenged
this view as Drosophila p53 is able regulate cell cycle upon
energy deprivation: the ‘‘tenured’’ mutation disrupts the
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mitochondrial electron transport chain and causes reduced
cellular ATP level, which leads to a G1/S checkpoint arrest
that requires Dmp53 [12]. Specifically, reduced ATP acti-
vates Dmp53, which in turn promotes the proteasomal
degradation of Cyclin E and cell cycle arrest [13]. These
results argue that Dmp53, as the vertebrate p53, induces
cell cycle arrest, although the mechanistic control and
execution have diverged partially during evolution. Thus,
the debate about whether Dmp53 acts more like p53 or p63
is still open, rather we favor that as the unique member of
p53 family, it is likely Drosophila p53 carries the ancestral
functions of all p53 family members (Fig. 1).
Since the cloning of Dmp53, studies in the fly primor-
dial germ cells, imaginal discs and adult photoreceptors
Fig. 1 The two isoforms of
Dmp53. TAD: transactivation
domain. DBD: DNA binding
domain. OD: oligomerization
domain. DDNp53 is the
predominant fly p53 isoform
that activates AiP via
the induction of mitogens
A B
C
Fig. 2 Drosophila p53 controls apoptosis, apoptosis-induced prolif-
eration and coordinates organ and systemic growth. (a) In the
presence of irreparable cellular damage, Dmp53 activates the
Drosophila pro-apoptotic genes: Rpr, Hid, Grim, which in turn
inhibit Diap1 activity to activate the caspase-mediate cell death. (b) In
the presence of apoptosis, the neighboring cells begin to proliferate to
regenerate the damaged tissue. Dmp53 facilitates such apoptosis-
induced proliferation by promoting the activation of Wingless (Wg),
Decapentaplegic (Dpp) and Notch (N) signaling pathways.
(c) Recently, it was discovered that Dmp53 can coordinate organ
and systemic growth in the presence of cellular stress or tissue injury.
For example, after the developing wing discs are subjected to certain
level of irradiation or metabolic stress, the growth of the entire wing
disc is delayed in a coordinated fashion to form a final well-
proportioned adult wing, and the larval growth and pupariation timing
is also delayed to allow the tissues and organ to repair. Dmp53 is
required in such organ and system growth coordination through a yet
unknown mechanism
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have not only elucidated the detailed mechanisms under-
lying Drosophila p53-mediated apoptosis, DNA repair and
homologous recombination, but also were among the first
to assign physiological and developmental functions to p53
[14–19]. Recently, it was shown that Dmp53 is selectively
activated in gonadal stem cells subjected to genotoxic or
oncogenic stress restricting their growth, thus making the
fly reproductive organs an attractive model to study p53
function in stem cells [20].
Beside these well-studied functions of p53, recent
studies in Drosophila have unraveled intriguing roles of
Dmp53 in promoting cell division in apoptosis-induced
proliferation, enhancing fitness and proliferation of the
winner cell in cell competition and coordinating growth at
the organ and organismal level in the context of stress
(Fig. 2). In this issue of Apoptosis, Simo´n et al. reports a
novel finding that Dmp53 interacts with Notch in the
developing wing and regulates N expression during apop-
tosis-induced proliferation (AiP) [21]. We therefore focus
this review on these new functions of Drosophila p53 and
discuss their relevance in carcinogenesis.
Dmp53 regulates apoptosis-induced proliferation (AiP)
In response to damage or injuries in the developing tissue,
apoptotic cells promote cell proliferation in the sur-
rounding tissue to repair and regenerate [22, 23]. Apop-
totic cells secret mitogens such as Wnt, TGFb or
Hedgehog (homologous to Drosophila Wg, Dpp and
Hedgehog/Hh, respectively), which in turn induce imme-
diate and local proliferation in the healthy surrounding
cells [24–26]. This phenomenon, now defined as the
apoptosis-induced proliferation, was first identified and
characterized in Drosophila [27–29] and is directly con-
trolled by Dmp53 [30]. AiP is distinct from ‘‘compensa-
tory proliferation’’ (CP), which is a complex global injury
response that requires coordinated and balanced local
proliferation, re-patterning of damaged organs and medi-
ating systemic growth delay at the level of the tissue and
the organism. How AiP contributes to CP remains an
open question [31].
AiP was first studied using ‘‘undead cells’’, which are
generated by subjecting the cells to a pro-apoptotic signal,
such as rpr or hid, but apoptosis is concomitantly inhib-
ited by the expression of the caspase inhibitor p35 [28,
29]. In this experimental setup, the undead cells con-
stantly activate the apoptotic cascade without undergoing
true apoptosis and produce large amount of mitogens that
induce hyperplastic growth of the tissue [27, 32]. These
studies have first identified the non-apoptotic functions of
caspases such as Dronc in promoting mitogen secretion
during AiP [33–35]. Importantly, they also uncovered the
requirement of Dmp53 and JNK for the production of
mitogens [29, 30, 36]. In the absence of Dmp53, the
undead cells fail to express Wg and tissue overprolifera-
tion is reduced [30]. This particular finding is the first to
indicate that besides mediating apoptosis, Dmp53 is also
absolutely required for the induction of mitogens and cell
proliferation during AiP.
There is evidence that such Dmp53-controlled prolifer-
ation and AiP program are conserved throughout evolution.
In the planarians, p53 regulates proliferation and self-
renewal in adult stem cell lineages [37]. Similarly in mouse
studies, p53 activation through the specific inactivation of
Mdm2 in the gut, a highly proliferative tissue, leads to
apoptosis and proliferation that compensates for cell loss
[38]. Furthermore, the AiP program has been shown to
promote head regeneration in the Cnidaria hydra [22], in
that apoptosis is both necessary and sufficient for Wnt3
production [39]. Interestingly, it was also shown that the
AiP program is central to the process of tumor repopulation
that occurs upon irradiation of cancer cells [40]. In this
study, Huang et al. showed that the induction of caspase 3
in irradiated tumor drives the expression of prostaglandin
E2, which potently induces proliferation and tumor
repopulation in xenograft mouse tumors. As mutations of
TP53 is found in 50 % of human cancers, it is an important
and interesting question to address if p53 can regulate AiP
program in cancerous cells that retain wild-type p53, and if
yes, how. Nevertheless, these results indicate that the
control of AiP can be therapeutically important in reducing
cancer relapse after radiation or chemotherapy.
Dmp53 regulates AiP through mechanisms involving
mitogen activation
What are the molecular underpinnings of the observation
that a single Dmp53 gene can regulate two seemingly
incompatible processes: apoptosis versus proliferation, in
the same cellular context? Part of the answer may arise
from the multiplicity of p53 transcriptional targets, which
respond differentially depending on stress intensity. It was
proposed that in vertebrates, low stress p53 targets promote
ROS detoxification, DNA repair while acute stress targets
induce apoptosis or senescence [1]. As in vertebrates,
Drosophila p53 regulates multiple targets essential for
apoptosis, DNA repair and proliferation [14, 21, 41]. How
does p53 distinguish between these targets upon stress level
remains largely unanswered, but a few studies of p53 iso-
forms provided some clues. In mammals such as mice and
humans, p53 expresses up to 12 protein isoforms generated
by alternative splicing, codon initiation sites and internal
promoters [42, 43]. In Drosophila, there are four annotated
transcripts for Dmp53, which leads to the expression of two
Apoptosis (2014) 19:1421–1429 1423
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detectable protein isoforms: Dp53 and DDNp53 (Fig. 1)
[41, 44]. Dp53 refers to the full length p53 protein that has
an intact transactivation domain and corresponds to the
human full-length (TA) p53. DDNp53 corresponds to the
N-terminally truncated human p53 isoforms. Historically,
DDNp53 was the first cloned isoform [8–10]. To distin-
guish the roles of Dmp53 isoforms in AiP, Dichtel-Danjoy
et al. studied the effect of Dp53 and DDNp53 overex-
pression in the developing wing imaginal disc [41].
DDNp53 induced potent expression of Wg and overpro-
liferation, while Dp53 only resulted in weak Wg expression
and proliferation. Importantly, the induction of Wg by
DDNp53 also occurred in the absence of both endogenous
Dmp53 isoforms, indicating that the DDNp53 activates its
own transcriptional targets needless of any input from the
full-length Dp53 isoform. These results indicate that
DDNp53 is the main fly p53 isoform controlling AiP. Thus,
each of the Drosophila p53 isoforms may assert specific
functions to mediate cell death and proliferation in the
regenerating tissue. Based on the findings of the overex-
pression studies, it will be interesting to further dissect the
detailed function of each Drosophila p53 isoform in AiP
using individual Dmp53 mutant isoforms.
In this issue of Apoptosis, Busturia and col. have
examined the contribution of Notch (N) signaling to AiP in
relation to DDNp53 [21]. The authors found that ectopic
expression of DDNp53 was sufficient to induce N expres-
sion and the proliferation induced by DDNp53 depends on
the level of N expression. The authors first demonstrated
that Dmp53 interacts with Notch genetically by studying
trans-heterozygotes where removing a copy of wild-type
Dmp53 enhances the notched wing phenotype in
N mutants. Then, by monitoring the expression of a GFP
reporter construct under the control of a Notch cis-regu-
latory element (Notch[2.7-NRE]-GFP) that contains a
putative p53 binding site, the authors showed that varying
Dmp53 protein levels regulate N gene transcription. This
study corroborates previous mouse studies showing that
p53 binds Notch1 promoter and that p53 silencing resulted
in reduced Notch expression [45, 46]. The study of cros-
stalks between Notch and p53 may be very relevant in the
growth control of cancer cells [47].
While overexpressing DDNp53 activates N and Wg
expression in the developing wing, it is unclear how N,
Wg, Dpp and Hh contribute to the different AiP paradigms.
It was proposed that distinct programs of AiP are activated
depending on the cellular state [23, 26]. For example, if
apoptosis is induced in the proliferating tissues such as the
imaginal wing disc or the anterior part of the eye disc, Wg,
Dpp and N are activated in a dronc- and dmp53-dependent
manner; while in differentiating tissues such as the pos-
terior part of the eye disc, Hh is preferentially activated in
the dying cells via the non-apoptotic activation of the
effector caspases Drice and Dcp1 [34]. Thus, distinct
apoptotic cascades can induce the AiP program, which in
turn activates tissue specific mitogenic signals to promote
proliferation and regeneration of the tissue.
An interesting observation is that DDNp53 induces
mitogen expression and proliferation even when apoptosis
is inhibited in dronc mutants [21, 36, 41]. This led to the
proposal that DDNp53 acts downstream of the apoptotic
pathway to induce the secretion of mitogens and cell pro-
liferation [41]. An alternative hypothesis is that DDNp53
can promote proliferation independently of apoptosis [21,
36]. However, testing the alternative hypothesis is difficult
since in virtually all the known experimental setups
employed to study the control of AiP by Drosophila p53,
the induction of proliferation by Dmp53 is prompted by
apoptosis upon stress. In the classic DNA damage
response, Dmp53 rapidly activates rpr expression and
hence the apoptosis cascade. A recent study by Shlevkov
and Morata further cements the tight association between
Dmp53 and the apoptotic cascade by showing that Dmp53
and JNK mutually activate each other and act upstream of
the pro-apoptotic genes (rpr, hid, grim) and establish a
positive feedback loop that amplifies the initial apoptotic
stimuli [48]. Dmp53 activates directly JNK independently
of its transcriptional activity, while JNK overactivation
induces Dmp53 expression [48–50]. Thus, in the model of
Shlevkov and Morata, most stress-induced cell death would
be due to the secondary activation of Dmp53 and JNK [48].
Based on these findings, it is an interesting challenge to
find a physiological context to support an experiment in
which Dmp53-induced proliferation is completely disso-
ciated from the apoptotic machinery.
AiP in physiological processes?
Another interesting conundrum is why the AiP program is
only induced in response to cell injury, but not in devel-
opmental apoptosis. In several fly developmental pro-
cesses, apoptosis is required to reduce the primordial germ
cell numbers in the embryo and eliminate the excess neu-
roblasts in the larva or the supernumerary interommatidial
retinal cell during pupal development, and some of these
processes are known to depend on Dmp53 [51–54]. Like in
the injury response, developmental apoptosis equally
engages the classical apoptotic cascade that induces rpr,
hid and grim expression, inhibits DIAP1 and ultimately
activates the initiator (dronc) and effector caspases (drice,
dcp1) [55], yet such developmental apoptosis has not been
observed to induce proliferation in the neighboring cells.
What are the molecular and cellular mechanisms that dis-
tinguish developmental apoptosis and injury-induced
apoptosis? The question is largely unexplored and we can
1424 Apoptosis (2014) 19:1421–1429
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only surmise a few answers. First, the initial signals that
trigger the apoptosis during development and upon injury
may be quite different. Second, the Dmp53-induced mito-
gen activation is only observed when AiP is induced fol-
lowing a damage response, thus creating the cellular
context for proliferation that is absent in developmental
apoptosis. Third, the extent of the activation of each of the
apoptotic pathway components is probably different in the
injury response versus developmental cell death, which
may subsequently impinge on Dmp53 regulation. There-
fore, it may be interesting to investigate if and how Dmp53
expression and function can be genetically or epigeneti-
cally altered in developmental apoptosis to cull unwanted
cells without activation of AiP.
Role of Dmp53 in coordinating growth at the organ
level
In addition to its role in locally controlling AiP as an injury
response, Dmp53 also coordinates growth at the organ and
possibly systemic level in the presence of genotoxic or
environmental stress. In multicellular organisms, growth
must be strictly coordinated to form well-proportioned
organs that conform to the size of the host. A few years
ago, in an elegant study, Mesquita et al. demonstrated that
Dmp53 is essential to coordinate growth in the Drosophila
imaginal wing disc upon growth challenge. Specifically,
the authors hampered growth in the posterior compart-
ment of the wing disc, either by the expression of Ricin, a
ribosome-inactivating toxin, or by the inhibition of insulin
pathway. The cell division and growth rate in the unaf-
fected compartment accordingly slow down to generate an
adult wing that is normally proportioned, even though the
final size is smaller than the wild-type wing (Fig. 2) [56].
Interestingly, when the authors repeated the same experi-
ments with impaired Dmp53 function in the wing, the final
adult wing is no longer well-proportioned, indicating that
Dmp53 non-autonomously induces growth delay in the
unaffected anterior compartment [56]. Furthermore, the
authors showed that only Dmp53, not the Dmp53-con-
trolled apoptotic machinery components, can mediate such
long-range growth delay when half of wing is growth-
impaired, suggesting that Dmp53 directs a yet unknown
mechanism that is independent of apoptosis to coordinate
organ growth. This Dmp53-mediated non-autonomous
growth delay strikingly contrasts with the results from the
previous AiP studies where Dmp53 and caspases promote
long-range, non-autonomous proliferation when apoptosis
is induced by IR or by the ectopic activation of Rpr or Hid.
How can one reconcile these seemingly opposite Dmp53-
mediated injury and repair responses? First of all, whether
the tissue damage is caused by IR, Ricin poisoning or
insulin inhibition, Dmp53-mediated cell death marked by
caspase-3 staining is activated autonomously in the dam-
aged tissue. However, unique to the Mesquita et al. study,
the cell death caused by Ricin expression or down-regu-
lating insulin response fails to activate mitogens necessary
for proliferation, even in the presence of Dmp53 and a
fully-operating apoptotic cascade controlled by Dmp53. If
one assumes a priori that Dmp53 directly activates mito-
gens such as Wg, TGF-b and Notch (as published in this
issue) to initiate cell proliferation, then why does Dmp53
fail to do so in the study by Mesquita et al.? The answer
may simply be that different kinds of injuries lead to dif-
ferent Dmp53 responses. Therefore, Dmp53 seems to
possess the intrinsic capacity to distinguish damage of
different nature, i.e. caused by massive DNA damage (IR)
or metabolic stress (InR impairment). As mentioned above,
the two different Dmp53 isoforms have different capacity
to mediate AiP [41]. Based on this knowledge, it is
intriguing to postulate that the different Dmp53 isoforms
are activated by different kind of cellular stress, so that one
isoform predominantly promotes proliferation and the
other coordinates growth delay depending on the stress
context. Lastly, by overexpression of PTEN or Ricin, the
mTOR pathway function is compromised; in mammalian
studies, p53 is both an upstream inhibitor and downstream
target of the mTOR signalling, which controls cellular and
systemic response during development and stress [57].
Therefore, it will be interesting to see if the long-range
growth delay mediated by Dmp53 impinges on the mTOR
pathway in an isoform-dependent fashion.
In addition to coordinating growth at the organ level,
Dmp53 participates to control systemic growth of the
organism in response to damage. If a developing
organism is subjected to severe injury, such as diffuse
irradiation, the overall development is delayed to enable
organ repair and regeneration [58]. One of the best
demonstrations of this principle uses Drosophila wing as
a regenerative model. For example, after irradiation,
wild-type fly larvae undergo developmental delay, but
emerge with normal-looking organs such as the wing. In
a recent study, Wells and Johnston found that after
general irradiation, Drosophila Dmp53 mutant larvae fail
to delay developmental timing, and adults emerge with
apparent missing tissues on the wing [36]. This obser-
vation confirms the idea that the local Dmp53-mediated
AiP and the system-wide CP response need to be coor-
dinated during development. How Dmp53 mediates the
coordination between organ regeneration and system
growth is an open question. Recent studies show that
Dilp8 is responsible for coordinating organ growth and
developmental timing [59]. It will be interesting to test
whether Dmp53 genetically interacts with Dilp8 in such
process.
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Role of Dmp53 in cell competition
Cell competition is a cellular phenomenon that occurs when
two populations of cells of different ‘‘fitness’’ encounter, and
the cells with ‘‘fitness advantages’’, termed ‘‘winner cells’’,
rapidly expand at the expense of the less fit cells, termed
‘‘loser cells’’ [60]. A widely used model of cell competition
is established in Drosophila wing discs where a population of
Myc-overexpressing cells can outcompete their neighboring
wild-type cells that are eliminated by apoptosis [61, 62]. In a
recent study by de la Cova et al., Dmp53 is shown to be
required for the dMyc overexpressing cells in the wing disc
to achieve such ‘‘supercompetitor’’ status through metabolic
reprogramming [63]. Specifically, overexpression of Myc
increases the glycolytic flux and activates Dmp53 expres-
sion. Interestingly, the authors demonstrated that Dmp53
asserts different metabolic control depending on the cellular
context: in non-competing cells that uniformly express
dMyc, dmp53 activation promotes oxidative phosphoryla-
tion to counteract the dMyc-induced glycotyic flux. In this
context, Dmp53 asserts its canonical role of the tumor sup-
pressor, in that it responds to oncogene deregulation and acts
to minimize the potentially deleterious effect of the activated
oncogene, which in this case, is mediated by Myc. However,
de la Cova et al. further demonstrate that in a heterogeneous
population of cells where dMyc is selectively activated,
Dmp53 is required for the increased glycolytic flux in the
Myc-overexpressing cells, which is an indispensible step for
the Myc-expressing cells to become the ‘‘winner cells’’.
Therefore, during cell competition, Dmp53 acts as an
accomplice of Myc to aid in realizing its oncogenic potential.
As cell competition is a predominant feature in cancer cell
expansion at the detriment of the neighboring normal cells,
this study furnishes disconcerting evidence that reveals the
cooperation between an oncogene and a tumor suppressor
gene to confer the winning status to cancer cells.
Dmp53 and the Hippo pathway
The Hippo signaling cascade is one of the most conserved
organ size control pathways in evolution [64–66]. By
phosphorylating Yorkie, the main downstream output the
Hippo pathway, the Hippo kinase complexes limit cellular
proliferation and permit apoptosis during cellular and
tissue growth [64–66]. Almost 10 years ago, a study by
Colombani et al. first demonstrated that in the presence of
IR damage, Dmp53 acts upstream of the Hippo pathway
to induce apoptosis [67]. Specifically, the authors first
induced apoptosis by irradiation or tissue-specific over-
expression of Dmp53 in the fly imaginal discs and found
that caspase-3 level is markedly reduced in mutant clones
of Hippo pathway components, suggesting that Hippo acts
downstream of Dmp53 to elicit cellular and tissue-wide
apoptotic response. Furthermore, in Kc cell lysate and
extracts from the Drosophila ovaries, IR treatment rapidly
leads to phosphorylation of Hippo at a threonine residue
(T195), and reducing or removing Dmp53 drastically
diminishes such Hippo phosphorylation, and consequently
dampens Hippo pathway activation in the presence a cell-
death signal. This work nicely demonstrates that Hippo
acts epistatically to Dmp53 to control the activation of
apoptosis. Now in the light of the finding that Dmp53 can
coordinate organ size and systemic growth in a stress
context, an intriguing question begs the answer: can
Dmp53 act in concert with the components of the Hippo
pathway to control and coordinate tissue growth? And
vice versa, does the Hippo pathway play a role in AiP in
the classic IR-induced damage model? We do not yet
have answers. However, the analysis of yorkie function
may hold some clues. It has been well-established that
Yorkie activates Diap1 to limit apoptosis during tissue
proliferation and growth [68]. Recently, a study from
Zhang and Cohen added the role of Dmp53 to the picture:
they first found that Yorkie negatively regulates the
expression of Rpr [69]. Reducing Yorkie level in the fly
inter-vein wing region leads to specific undergrowth,
presumably due to the over-activation of Rpr, and such
undergrowth can be partially rescued by the concomitant
expression of a dominant negative Dmp53 in the same
wing region. Presumably, Yorkie knockdown destabilizes
Diap1, hence activates Rpr and the subsequent Dronc-
Dmp53 feedback loop [48, 68]. However, the authors
observed that in their particular experimental setting, the
observed Rpr and Dmp53 activation is independent of the
feedback loop, but a result from inferred physical binding
between the Drosophila ASPP1 homologue and Dmp53,
which can activate the downstream apoptotic genes [70,
71]. The authors do not further demonstrate how and to
what extend Dmp53 is activated by Yorkie down-regu-
lation, therefore the results can have different implica-
tions. One possibility is that physiological Yorkie activity
is required to keep Dmp53 level in check to prevent
ectopic apoptosis during development. Another interesting
possibility is that, despite its seeming inactivity, Dmp53
may act as a sensor of the Hippo pathway status through
Yorkie. For example, one may postulate that in actively
dividing tissue like the wing disc, dampening Yorkie
activity compromises the normal cellular growth poten-
tial, hence reduces the ‘‘fitness’’ of the cells. As Dmp53
can act as a sensor for cellular ‘‘fitness’’ as mentioned in
the previous section, Yorkie knockdown can lead to
enhanced Dmp53 activity to promote apoptosis. These
two mechanisms are not necessarily mutually exclusive.
Furthermore, can such proposed Dmp53-Yorkie interac-
tion coordinate the growth of a developing organ? The
1426 Apoptosis (2014) 19:1421–1429
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answers can only come from more detailed study of
Dmp53 interaction with the Hippo pathway components.
Conclusions
Studies of p53 in the past 35 years have depicted the many
facets of p53 functions that are forever evolving. We now
recognize that besides being the classic ‘‘guardian of the
genome’’ [72], p53 participates in the regulation of com-
plex physiological and developmental processes [43]. With
only one p53 family member expressed as two detectable
isoforms, Drosophila is a genetically tractable model to
explore the ‘‘primordial’’ functions of p53 in addition to its
well-known functions in mediating apoptosis in the pre-
sence of genotoxic stress. In fact, even such canonical
Dmp53 function is more complex than we first realized, as
studies begin to unravel the roles of Dmp53 isoforms in
controlling AiP and programmed cell death at the same
time in the same tissue. The molecular details of these
processes require future investigation. Furthermore, studies
in Drosophila pioneered many founding works in identi-
fying the physiological functions of p53, including the
recent discoveries of the role of Dmp53 in controlling
organ size, system growth and cell competition in the
presence of stress. From an evolutionary point of view, is
this kind of growth-control function part of the ‘‘primor-
dial’’ p53 functions? Four years ago, a study from John
Abram’s laboratory discovered that Dmp53 mediates
meiotic recombination in the germ-line, and proposed that
such primordial function of p53 is the origin of the geno-
toxic stress response [19]. Now an interesting question is
whether the AiP mediated by Dmp53 precedes or succeeds
the growth control function of Dmp53 during evolution.
The answer will certainly be complex and unexpected, as
much as it has been in the past 35 years.
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